DINUTUXIMAB BETA for Neuroblastoma recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 13 adverse event reports in the FDA FAERS database where DINUTUXIMAB BETA was used for Neuroblastoma recurrent.

Most Reported Side Effects for DINUTUXIMAB BETA

Side Effect	Reports	%	Deaths	Hosp.
Off label use	82	52.2%	22	7
Pyrexia	57	36.3%	2	7
Pain	46	29.3%	3	3
Death	20	12.7%	20	0
Neoplasm progression	20	12.7%	14	0
Device related bacteraemia	17	10.8%	0	0
Device related infection	16	10.2%	0	0
Diarrhoea	11	7.0%	1	1
Therapy partial responder	11	7.0%	6	0
Cough	10	6.4%	0	0
Rash	10	6.4%	1	0
Cholestasis	7	4.5%	0	7
Pruritus	7	4.5%	1	0
Acute myeloid leukaemia	6	3.8%	0	0
Alanine aminotransferase abnormal	6	3.8%	0	0